The reduction in force (RIF) layoffs have affected employees across "multiple HHS divisions" and follow the shutdown of the ...

Kelun-Biotech has picked up another first for its TROP2-targeting antibody-drug conjugate (ADC) sacituzumab tirumotecan ...

AstraZeneca has become the second pharma group, after Pfizer, to reach an agreement with the Trump administration on a deal ...

Faced with these compounding challenges, biotech and pharmaceutical companies increasingly require additional agility, ...

"Antimicrobial resistance is outpacing advances in modern medicine, threatening the health of families worldwide," said WHO ...

UCB's experimental medicine for rare disease thymidine kinase 2 deficiency (TK2d) has been shown to reduce the risk of death ...

UCB's experimental medicine for rare disease thymidine kinase 2 deficiency (TK2d) has been shown to reduce the risk of death ...

The European Society for Medical Oncology (ESMO) 2025 will take place 17th to 21st October in Berlin, Germany. The Congress ...

Novo Nordisk has agreed to buy Akero Therapeutics and its drug candidate for metabolic dysfunction-associated steatohepatitis ...

Karen Westaway is CEO of ValueBase. She is a health equity evangelist passionate about accelerating access to innovative ...

Kronos was bought out earlier this year for a knockdown price of around $35 million by serial biotech acquisition specialist ...

A jury in a Los Angeles, California court has ordered the company to pay an eye-watering $966 million to the family of Mae ...